Lenka L. Allan

857 total citations
17 papers, 637 citations indexed

About

Lenka L. Allan is a scholar working on Immunology, Molecular Biology and Cancer Research. According to data from OpenAlex, Lenka L. Allan has authored 17 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 4 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Lenka L. Allan's work include Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (6 papers) and Immunotherapy and Immune Responses (4 papers). Lenka L. Allan is often cited by papers focused on Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (6 papers) and Immunotherapy and Immune Responses (4 papers). Lenka L. Allan collaborates with scholars based in United States, Canada and Australia. Lenka L. Allan's co-authors include David H. Sherr, Mark E. Hahn, Peter van den Elzen, Frederick K. Kozak, Rusung Tan, Brian K. Chung, Robert L. Tanguay, Richard S. Pollenz, Sibel I. Karchner and Brad R. Evans and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Lenka L. Allan

16 papers receiving 627 citations

Peers

Countries citing papers authored by Lenka L. Allan

Since Specialization

Citations

This map shows the geographic impact of Lenka L. Allan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lenka L. Allan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lenka L. Allan more than expected).

Fields of papers citing papers by Lenka L. Allan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lenka L. Allan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lenka L. Allan. The network helps show where Lenka L. Allan may publish in the future.

Co-authorship network of co-authors of Lenka L. Allan

This figure shows the co-authorship network connecting the top 25 collaborators of Lenka L. Allan. A scholar is included among the top collaborators of Lenka L. Allan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lenka L. Allan. Lenka L. Allan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	The role of ANGPTL4 in cancer: A meta-analysis of observational studies and multi-omics investigation 2025 ·PLoS ONE ·(unknown), (unknown), (unknown), (unknown), Lenka L. Allan, (unknown), (unknown)	0
2	Chronic lymphocytic leukemia patients with HLA-B27 referred for allogeneic hematopoietic stem cell transplantation do not have worse outcomes: Results of a population-based case series analysis in British Columbia, Canada 2019 ·Leukemia Research ·(unknown), Jonathan Chan, Hélène Bruyèrè, Lenka L. Allan, Alina S. Gerrie, Cynthia L. Toze	1
3	Autoreactivity to Sulfatide by Human Invariant NKT Cells 2017 ·The Journal of Immunology ·(unknown), (unknown), Enrico Girardi, Naoki Kitano, Lenka L. Allan, Victor Liu, (unknown), William J. Panenka, (unknown), Chi‐Huey Wong, Serge Van Calenbergh, Dirk M. Zajonc, Peter van den Elzen	17
4	Conjugation of A and B Blood Group Structures to Silica Microparticles for the Detection of Antigen-Specific B Cells 2016 ·Bioconjugate Chemistry ·(unknown), E. Dijke, (unknown), (unknown), Lu Zou, (unknown), Peter J. Meloncelli, Jeremy A. Bau, Lenka L. Allan, Todd L. Lowary, Lori J. West, Christopher W. Cairo, Jillian M. Buriak	8
5	Characterization of pathogenic human monoclonal autoantibodies against GM-CSF 2013 ·Proceedings of the National Academy of Sciences ·Yanni Wang, Christy A. Thomson, Lenka L. Allan, (unknown), (unknown), Timothy R. Hercus, Tracy L. Nero, Amanda Turner, Michael W. Parker, (unknown), Thomas K. Waddell, Gary P. Anderson, John A. Hamilton, John W. Schrader	30
6	Innate immune control of EBV-infected B cells by invariant natural killer T cells 2013 ·Blood ·Brian K. Chung, (unknown), Lenka L. Allan, (unknown), (unknown), Catherine M. Biggs, Mohammad R. Hasan, Frederick K. Kozak, Peter van den Elzen, John J. Priatel, Rusung Tan	78
7	1039 A High Throughput Screening Platform for the Identification of Small Molecule Inhibitors of the E3 Ligase E6AP 2012 ·European Journal of Cancer ·Ian P. Street, Kurt Lackovic, (unknown), Brendon J. Monahan, Kamil Wolyniec, (unknown), (unknown), Hendrik Falk, Lenka L. Allan, Patricia A. Pilling	1
8	CD1d and CD1c Expression in Human B Cells Is Regulated by Activation and Retinoic Acid Receptor Signaling 2011 ·The Journal of Immunology ·Lenka L. Allan, (unknown), (unknown), Brian K. Chung, Frederick K. Kozak, Rusung Tan, Peter van den Elzen	48
9	Disruption of human plasma cell differentiation by an environmental polycyclic aromatic hydrocarbon: a mechanistic immunotoxicological study 2010 ·Environmental Health ·Lenka L. Allan, David H. Sherr	22
10	Apolipoprotein-mediated lipid antigen presentation in B cells provides a pathway for innate help by NKT cells 2009 ·Blood ·Lenka L. Allan, (unknown), (unknown), Brian K. Chung, Frederick K. Kozak, Rusung Tan, Peter van den Elzen	65
11	Regulation of constitutive and inducible AHR signaling: Complex interactions involving the AHR repressor 2008 ·Biochemical Pharmacology ·Mark E. Hahn, Lenka L. Allan, David H. Sherr	125
12	Su.35. Epstein-Barr Virus Downregulates B Cell Surface CD1d to Evade Natural Killer T Cell Detection 2008 ·Clinical Immunology ·Brian K. Chung, Lenka L. Allan, (unknown), John J. Priatel, Peter van den Elzen, Rusung Tan	1
13	Repression of Aryl Hydrocarbon Receptor (AHR) Signaling by AHR Repressor: Role of DNA Binding and Competition for AHR Nuclear Translocator 2007 ·Molecular Pharmacology ·Brad R. Evans, Sibel I. Karchner, Lenka L. Allan, Richard S. Pollenz, Robert L. Tanguay, Matthew J. Jenny, David H. Sherr, Mark E. Hahn	117
14	CYP1A1 in polycyclic aromatic hydrocarbon-induced B lymphocyte growth suppression 2006 ·Biochemical and Biophysical Research Communications ·Lenka L. Allan, Jennifer J. Schlezinger, (unknown), David H. Sherr	22
15	Constitutive Activation and Environmental Chemical Induction of the Aryl Hydrocarbon Receptor/Transcription Factor in Activated Human B Lymphocytes 2005 ·Molecular Pharmacology ·Lenka L. Allan, David H. Sherr	54
16	Environmental Chemical-Induced Bone Marrow B Cell Apoptosis: Death Receptor-Independent Activation of a Caspase-3 to Caspase-8 Pathway 2005 ·Molecular Pharmacology ·Heui‐Young Ryu, (unknown), Jennifer J. Schlezinger, Lenka L. Allan, Songqing Na, David H. Sherr	26
17	Bone Marrow Stromal-B Cell Interactions in Polycyclic Aromatic Hydrocarbon-Induced Pro/Pre-B Cell Apoptosis 2003 ·Toxicological Sciences ·Lenka L. Allan	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact